6-phenylhexyl isothiocyanate has been researched along with Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiao, JW; Hong, L; Huang, Y; Ma, X; Zou, Y | 1 |
Ahmed, T; Beklemishev, A; Chiao, JW; Liu, D; Lu, L; Ma, X; Seiter, K | 1 |
2 other study(ies) available for 6-phenylhexyl isothiocyanate and Leukemia
Article | Year |
---|---|
Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia.
Topics: Acetylation; Acute Disease; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Case-Control Studies; Child; Decitabine; DNA Methylation; Female; Histone Deacetylase Inhibitors; Histone-Lysine N-Methyltransferase; Histones; Humans; Hydroxamic Acids; Isothiocyanates; Leukemia; Male; Middle Aged; Protein Processing, Post-Translational; Young Adult | 2012 |
The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Cyclins; Humans; Isothiocyanates; Leukemia; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Retinoblastoma Protein | 2006 |